Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

Autor: Allen, Rachel, Bryden, Peter, Grotzinger, Kelly M., Stapelkamp, Ceilidh, Woods, Bethan
Zdroj: In Value in Health July-August 2016 19(5):614-622
Databáze: ScienceDirect